- Home
- EVC vs XBIT Comparison
EVC vs XBIT Comparison
Compare EVC & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVC
- XBIT
- Stock Information
- Founded
- EVC 1996
- XBIT 2005
- Country
- EVC United States
- XBIT United States
- Employees
- EVC N/A
- XBIT N/A
- Industry
- EVC Broadcasting
- XBIT Pharmaceuticals and Biotechnology
- Sector
- EVC Industrials
- XBIT Health Care
- Exchange
- EVC Nasdaq
- XBIT Nasdaq
- Market Cap
- EVC 229.5M
- XBIT 194.5M
- IPO Year
- EVC 2000
- XBIT 2015
- Fundamental
- Price
- EVC $2.20
- XBIT $2.99
- Analyst Decision
- EVC Hold
- XBIT
- Analyst Count
- EVC 1
- XBIT 0
- Target Price
- EVC $1.75
- XBIT N/A
- AVG Volume (30 Days)
- EVC 230.5K
- XBIT 54.9K
- Earning Date
- EVC 03-04-2025
- XBIT 03-14-2025
- Dividend Yield
- EVC 9.09%
- XBIT N/A
- EPS Growth
- EVC N/A
- XBIT N/A
- EPS
- EVC N/A
- XBIT N/A
- Revenue
- EVC $1,146,066,000.00
- XBIT N/A
- Revenue This Year
- EVC N/A
- XBIT N/A
- Revenue Next Year
- EVC N/A
- XBIT N/A
- P/E Ratio
- EVC N/A
- XBIT N/A
- Revenue Growth
- EVC 122.49
- XBIT N/A
- 52 Week Low
- EVC $1.33
- XBIT $2.99
- 52 Week High
- EVC $3.92
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- EVC 46.64
- XBIT 31.96
- Support Level
- EVC $2.14
- XBIT $3.03
- Resistance Level
- EVC $2.30
- XBIT $3.32
- Average True Range (ATR)
- EVC 0.08
- XBIT 0.19
- MACD
- EVC 0.01
- XBIT 0.04
- Stochastic Oscillator
- EVC 50.00
- XBIT 0.00
About EVC Entravision Communications Corporation
Entravision Communications Corp is a global advertising solutions, media, and technology company. Its operations encompass integrated marketing and media solutions, comprised of television, radio, and digital properties and data analytics services. The company operates in television broadcasting, audio broadcasting, and digital media segments. The Company's digital segment, whose operations are located in Europe, Latin America, Asia, the United States, and Africa. The Company's television and audio operations reach and engage U.S. Hispanics in the United States.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.